Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05390411
Other study ID # 13943
Secondary ID R56HL159216R01HL
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date March 6, 2023
Est. completion date February 2027

Study information

Verified date April 2024
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary goal of this study is to assess real-world effectiveness and implementation of an evidence-based multi-component strategy to achieve equity in the allocation rate of advanced heart failure therapies, heart transplants and ventricular assist devices. This study proposes to implement evidence-based strategies that reduce bias, replace subjective evaluations with objective criteria, and improve group dynamics in a randomized cluster trial. This rigorously designed trial may inform national guidelines for advanced heart failure therapy allocation, and data are likely to be generalizable to other organ replacement treatments and advanced chronic disease decision-making processes.


Description:

Standardized protocols can reduce the impact of implicit bias but are underused. Since the Institute of Medicine's report, "Unequal Treatment", multiple studies have confirmed that standardization of decision- making processes reduces bias, but bias in the allocation of advanced therapies has not been addressed. Using an evidence-based framework for behavior change [Capability, Opportunity, and Motivation for Behavior Change/Behavior Change Wheel (COM-B/BCW)], a standardized protocol strategy Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) was developed, that addresses significant barriers to equity in advanced therapies:1) bias, 2) subjectivity in evaluation of social support and adherence, and 3) poor group dynamics. Thus, SOCIAL HF includes: 1) evidence-based bias training tailored for HF, 2) restriction to objective evaluations of social support and adherence, and 3) environmental restructuring and modeling of meeting settings to include anonymous electronic voting and equitable seating arrangement. In complex decision-making that includes individuals and groups, the standardized protocol strategy, SOCIAL HF, has the greatest likelihood of achieving health equity in advanced HF. The goal is to assess real-world effectiveness (Aim 1) and implementation (Aim 2) of SOCIAL HF for allocation of advanced HF therapies, heart transplant and ventricular assist device implantation. A randomized controlled cluster design will be used to test the effectiveness of SOCIAL HF strategy. Investigators will evaluate Implementation of SOCIAL HF across study sites using mixed-methods in order to learn optimal implementation strategies to achieve equity. Investigators will use normalization process theory to evaluate how SOCIAL HF affects processes and outcomes important to advanced HF centers (e.g. fidelity/variation). Investigators will use RE-AIM framework (reach, effectiveness, adoption, implementation, and maintenance) to evaluate factors that promote reach and adoption and resources needed for implementation.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 1463
Est. completion date February 2027
Est. primary completion date February 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Active United Network for Organ Sharing heart transplant and ventricular assist device center 2. Centers that routinely evaluate at least 50 minoritized racial/ethnic patients and 50 women for advanced heart failure therapies (heart transplant and ventricular assist device) over 2 years 3. Advanced therapy professionals from participating centers (i.e., coordinators, physicians, pharmacists, nurses, social workers) 4. Participants for the interview portion will be a subset of otherwise eligible advanced therapy professionals who are included on selection meeting attendance sheets at an included center Exclusion Criteria: 1. Centers unable to fully participate in the training and evaluation measures 2. If the center ceases to be an active heart failure/transplant center

Study Design


Intervention

Behavioral:
SOCIAL HF
participate in SOCIAL HF training

Locations

Country Name City State
United States Indiana University Indianapolis Indiana

Sponsors (2)

Lead Sponsor Collaborator
Indiana University National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of evaluated minoritized racial/ethnic patients and women patients receiving advanced therapies. Up to 3 years
Primary Change in SOCIAL HF fidelity from time of training completion (month 2) to time study target has been reached (up to 2 years) and 6 months after reaching study target (up to 2.5 years) Evaluated as barriers, facilitators, and variability in adoption, reach, implementation and maintenance through structured interviews.
Study target is defined as time 50 patients of color and 50 women have been evaluated for advanced heart failure therapies per center.
Month 2, up to 2 years, and up to 2.5 years
Secondary Change from baseline knowledge, attitudes, and self-reported behavior change among clinicians at 2 months and time at which study target has been reached (up to 2 years) Multiple survey responses by participants will indicate knowledge, attitudes, and self-reported behavior changes over time.
Study target is defined as time 50 patients of color and 50 women have been evaluated for advanced heart failure therapies.
Baseline, 2 months, and up to 2 years
Secondary Discussion themes during allocation meetings across patient race/ethnicity and gender Transcriptions of meetings will be qualitatively evaluated over time. Baseline, 2 months, and up to 2 years
Secondary Change from baseline sum group function scores at 2 months and time at which study target has been reached (up to 2 years) The de Groot Critically Reflective Diagnoses protocol objectively measures categories associated with group function including challenging groupthink, critical opinion sharing, research utilization, openness to mistakes, asking and giving feedback, and experimentation. Each category is scaled from 1-4 (high-low), 1 = demonstrating interaction and reflection, 2 = reflective on an individual basis, 3 = non-reflective and non-interactive, and 4 = restricted.
Study target is defined as time 50 patients of color and 50 women have been evaluated for advanced heart failure therapies per center.
Baseline, 2 months, and up to 2 years
Secondary Adoption of SOCIAL HF Proportion of eligible advanced therapy professionals who participate in training 2 months
Secondary Reach of SOCIAL HF Proportion of patients evaluated using any parts of SOCIAL HF From 2 months up to 2 years
Secondary Implementation of SOCIAL HF Proportion of patients evaluated using all parts of SOCIAL HF From 2 months up to 2 years
See also
  Status Clinical Trial Phase
Completed NCT01799291 - Cognitive De-Biasing and the Assessment of Pediatric Bipolar Disorder N/A
Recruiting NCT03886025 - Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making N/A
Completed NCT03185715 - Oocyte Recipient's Decision in the Number of Embryos to be Transferred N/A
Completed NCT05974943 - The Effect of Problem Solving and Decision Making Training Given to Nurses Managers N/A
Terminated NCT05024903 - A Novel E-health Platform Phase 2/Phase 3
Completed NCT04509063 - Investigating Public Enthusiasm for Mammography Screening in Denmark N/A
Completed NCT03762239 - Effect of Air Pollution on the Cognitive Function of Adolescents N/A
Not yet recruiting NCT06081842 - Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria N/A
Completed NCT01190488 - Feasibility Of An Advanced Care Decision Aid Among Patients And Physicians_Matlock N/A
Active, not recruiting NCT04466865 - A Communication Tool to Assist Older Adults Facing Dialysis Choices N/A
Active, not recruiting NCT06046625 - Needs and Preferences of Patients With Head-neck Cutaneous SCC
Completed NCT03181841 - Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals Phase 1
Recruiting NCT03554694 - Gut-brain Axis, Brain Function, and Behaviour. N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Completed NCT04000802 - Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers
Completed NCT04034979 - Evaluation of a Decision Aid About Life-sustaining Therapies N/A
Active, not recruiting NCT05173922 - "Safety in Dementia": An Online Caregiver Intervention N/A
Withdrawn NCT01098864 - Transcranial Magnetic Stimulation of the Prefrontal Cortex: Effects on Risky Decision Making and Temporal Discounting. N/A
Recruiting NCT05364801 - Impact of Anxiety on the Decision-making Processes of Anesthesiologists
Completed NCT06355999 - Levari Exp.20: 2D - Partial Feedback N/A

External Links